James Kedrowski

Taro Pharmaceutical Industries Ltd. engages in the development, manufacturing and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.

Part of Sun Pharmaceutical Industries Ltd., Chattem Chemicals, Inc. is a manufacturer of active pharmaceutical ingredients and performance chemicals used in consumer and industrial markets. The company is based in Chattanooga, TN. The company's products are used worldwide in a wide range of custom formulated products and industrial applications. Chattem Chemicals was acquired by Sun Pharmaceutical Industries Ltd. from Elcat, Inc. on November 26, 2008.

Taro Pharmaceuticals, Inc. manufacturer and supplier of topical dermatological products. It’s products includes Taro Rx and Taro OTC. It develops creams ointments and gels and also have a growing line of solid dosage from products. It’s customer includes wholesalers, drugstore chains, mass volume retailers, healthcare institutions, independent drug stores and discount retailers. The company was founded in 1950 and is headquartered in Brampton, Canada.